Martin, L. et al. Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J. Cachexia Sarcopenia Muscle 12, 1189–1202 (2021).
Article PubMed PubMed Central Google Scholar
Babic, A. et al. Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer. Nat. Commun. 14, 4317 (2023).
Article CAS PubMed PubMed Central Google Scholar
Klassen, P., Schiessel, D. L. & Baracos, V. E. Adverse effects of systemic cancer therapy on skeletal muscle: myotoxicity comes out of the closet. Curr. Opin. Clin. Nutr. Metab. Care 26, 210–218 (2023).
Roeland, E. J., Bohlke, K., Baracos, V. E., Smith, T. J. & Loprinzi, C. L. Cancer cachexia: ASCO guideline rapid recommendation update. J. Clin. Oncol. 41, 4178–4179 (2023).
Sandhya, L. et al. Randomized double-blind placebo-controlled study of olanzapine for chemotherapy-related anorexia in patients with locally advanced or metastatic gastric, hepatopancreaticobiliary, and lung cancer. J. Clin. Oncol 41, 2617–2627 (2023).
Article CAS PubMed Google Scholar
Groarke, J. D. et al. Ponsegromab for the treatment of cancer cachexia. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2409515 (2024).
Kadakia, K. C., Hamilton-Reeves, J. M. & Baracos, V. E. Current therapeutic targets in cancer cachexia: a pathophysiologic approach. Am. Soc. Clin. Oncol. Educ. Book 43, e389942 (2023).
Article PubMed PubMed Central Google Scholar
Roeland, E. J. et al. Management of cancer cachexia: ASCO guideline. J. Clin. Oncol. 38, 2438–2453 (2020).
Article CAS PubMed Google Scholar
Temel, J. S. et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17, 519–531 (2016).
Article CAS PubMed Google Scholar
Amano, K. et al. Development and validation of questionnaires for eating-related distress among advanced cancer patients and families. J. Cachexia Sarcopenia Muscle 14, 310–325 (2023).
留言 (0)